Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among Women's Health Initiative postmenopausal women.
The Journal Of Clinical Endocrinology And Metabolism
Chan, Kei Hang K KH; Niu, Tianhua T; Ma, Yunsheng Y; You, Nai-chieh Y NC; Song, Yiqing Y; Sobel, Eric M EM; Hsu, Yi-Hsiang YH; Balasubramanian, Raji R; Qiao, Yongxia Y; Tinker, Lesley L; Liu, Simin S
Matarin, Mar M; Brown, W Mark WM; Dena, Hernandez H; Britton, Angela A; De Vrieze, Fabienne Wavrant FW; Brott, Thomas G TG; Brown, Robert D RD; Worrall, Bradford B BB; Case, L Douglas LD; Chanock, Stephen J SJ; Metter, E Jeffrey EJ; Ferruci, Luigi L; Gamble, Dale D; Hardy, John A JA; Rich, Stephen S SS; Singleton, Andrew A; Meschia, James F JF
Sequence variation in PPARG may underlie differential response to troglitazone.
Diabetes
Wolford, Johanna K JK; Yeatts, Kimberly A KA; Dhanjal, Sharanjeet K SK; Black, Mary Helen MH; Xiang, Anny H AH; Buchanan, Thomas A TA; Watanabe, Richard M RM